These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24580965)

  • 1. Dermatoscopic findings in cutaneous Rosai-Dorfman disease and response to low-dose thalidomide.
    Wang F; Zhou H; Luo DQ; Han JD; Chen MK
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):350-2. PubMed ID: 24580965
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.
    Tjiu JW; Hsiao CH; Tsai TF
    Br J Dermatol; 2003 May; 148(5):1060-1. PubMed ID: 12786846
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic challenge of dapsone in the treatment of purely cutaneous Rosai-Dorfman disease.
    Chang HS; Son SJ; Cho KH; Lee JH
    Clin Exp Dermatol; 2011 Jun; 36(4):420-2. PubMed ID: 21564180
    [No Abstract]   [Full Text] [Related]  

  • 5. Facial Cutaneous Rosai-Dorfman Disease.
    Flores-Terry MÁ; Romero-Aguilera G; González-López L; García-Arpa M
    Actas Dermosifiliogr; 2017 Jun; 108(5):480-482. PubMed ID: 28109522
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous Rosai-Dorfman disease of the face with a leonine appearance: successful response to dapsone.
    Lee YI; Kim SK; Oh SH; Kim DY
    Eur J Dermatol; 2018 Apr; 28(2):255-256. PubMed ID: 29400286
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosai-Dorfman disease successfully treated with thalidomide: A case report.
    Shahidi-Dadras M; Hamedani B; Niknezhad N; Ghilizadeh N
    Dermatol Ther; 2019 Sep; 32(5):e13005. PubMed ID: 31228316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosai-Dorfman disease: three difficult-to-diagnose cases.
    Du J; Ding X; Cai L; Sun P; Zhou C; Zhang J
    Eur J Dermatol; 2010; 20(5):650-1. PubMed ID: 20621850
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
    Sun NZ; Galvin J; Cooper KD
    JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
    [No Abstract]   [Full Text] [Related]  

  • 10. Dense Papules on the Face: A Quiz.
    Zhou H; Zhao Q; Zhao L; Shang Q; Li J; Geng S
    Acta Derm Venereol; 2019 Sep; 99(10):935-936. PubMed ID: 30938828
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous Rosai-Dorfman disease.
    Ohnishi A; Yoshida Y; Yamamoto O
    J Dermatol; 2008 Sep; 35(9):604-5. PubMed ID: 18837709
    [No Abstract]   [Full Text] [Related]  

  • 12. An unusual case of multiple cutaneous Rosai-Dorfman disease involving two separate parts of the body.
    Jia J; Tian Q; Zhang H; Zheng Y
    Int J Dermatol; 2017 May; 56(5):576-578. PubMed ID: 28255989
    [No Abstract]   [Full Text] [Related]  

  • 13. Thalidomide as a potential treatment for scleromyxedema.
    Caradonna S; Jacobe H
    Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
    [No Abstract]   [Full Text] [Related]  

  • 14. Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.
    Rubinstein M; Assal A; Scherba M; Elman J; White R; Verma A; Strakhan M; Mohammadi F; Janakiram M
    Am J Hematol; 2016 Feb; 91(2):E1. PubMed ID: 26502013
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Pagel JM; Lionberger J; Gopal AK; Sabath DE; Loeb K
    Am J Hematol; 2007 Dec; 82(12):1121-2. PubMed ID: 17696200
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed diagnosis of cutaneous Rosai-Dorfman disease with distinctive histologic features in a Malayan man.
    Choon SE; Moktar Z; Ghani GA
    Arch Dermatol; 2008 Jan; 144(1):120-1. PubMed ID: 18209186
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cutaneous revelation of Rosai-Dorfman disease: 7 cases].
    Vuong V; Moulonguet I; Cordoliani F; Crickx B; Bezier M; Vignon-Pennamen MD; Flageul B; Bagot M; Petit A
    Ann Dermatol Venereol; 2013 Feb; 140(2):83-90. PubMed ID: 23395488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance.
    Chan CC; Chu CY
    Arch Dermatol; 2006 Apr; 142(4):428-30. PubMed ID: 16618860
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dermoscopic features of cutaneous Rosai-Dorfman disease].
    Avilés-Izquierdo JA; Parra Blanco V; Alfageme Roldán F
    Actas Dermosifiliogr; 2012 Jun; 103(5):446-8. PubMed ID: 22264933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.